Wells Fargo & Company MN Cuts Stock Holdings in Blueprint Medicines Co. (NASDAQ:BPMC)
Wells Fargo & Company MN reduced its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 38.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 40,732 shares of the biotechnology company’s stock after selling 25,925 shares during the period. Wells Fargo & Company MN’s holdings in Blueprint Medicines were worth $3,553,000 as […]
Wells Fargo & Company MN reduced its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 38.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 40,732 shares of the biotechnology company’s stock after selling 25,925 shares during the period. Wells Fargo & Company MN’s holdings in Blueprint Medicines were worth $3,553,000 as […]